
Health and Wellness
Groundbreaking AI Partnership: Novo Nordisk and OpenAI to Speed Drug Development
Novo Nordisk and OpenAI have formed a groundbreaking AI partnership to accelerate the development of new weight loss dru…
James Whitfield·
3 articles

Novo Nordisk and OpenAI have formed a groundbreaking AI partnership to accelerate the development of new weight loss dru…

Novo Nordisk’s new Wegovy HD weight loss, a 7.2 mg semaglutide dose, approved by FDA, showed 21% weight loss in trials.…

Novo Nordisk’s CagriSema trails Eli Lilly’s tirzepatide in weight loss trial. Shares react. FDA decision awaited. Higher…